Correlation Between Enanta Pharmaceuticals and Evoke Pharma
Can any of the company-specific risk be diversified away by investing in both Enanta Pharmaceuticals and Evoke Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enanta Pharmaceuticals and Evoke Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enanta Pharmaceuticals and Evoke Pharma, you can compare the effects of market volatilities on Enanta Pharmaceuticals and Evoke Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enanta Pharmaceuticals with a short position of Evoke Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enanta Pharmaceuticals and Evoke Pharma.
Diversification Opportunities for Enanta Pharmaceuticals and Evoke Pharma
0.12 | Correlation Coefficient |
Average diversification
The 3 months correlation between Enanta and Evoke is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Enanta Pharmaceuticals and Evoke Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evoke Pharma and Enanta Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enanta Pharmaceuticals are associated (or correlated) with Evoke Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evoke Pharma has no effect on the direction of Enanta Pharmaceuticals i.e., Enanta Pharmaceuticals and Evoke Pharma go up and down completely randomly.
Pair Corralation between Enanta Pharmaceuticals and Evoke Pharma
Given the investment horizon of 90 days Enanta Pharmaceuticals is expected to generate 0.55 times more return on investment than Evoke Pharma. However, Enanta Pharmaceuticals is 1.83 times less risky than Evoke Pharma. It trades about -0.45 of its potential returns per unit of risk. Evoke Pharma is currently generating about -0.26 per unit of risk. If you would invest 1,095 in Enanta Pharmaceuticals on September 2, 2024 and sell it today you would lose (235.00) from holding Enanta Pharmaceuticals or give up 21.46% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enanta Pharmaceuticals vs. Evoke Pharma
Performance |
| Timeline |
| Enanta Pharmaceuticals |
| Evoke Pharma |
Enanta Pharmaceuticals and Evoke Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enanta Pharmaceuticals and Evoke Pharma
The main advantage of trading using opposite Enanta Pharmaceuticals and Evoke Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enanta Pharmaceuticals position performs unexpectedly, Evoke Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evoke Pharma will offset losses from the drop in Evoke Pharma's long position.| Enanta Pharmaceuticals vs. Monte Rosa Therapeutics | Enanta Pharmaceuticals vs. Design Therapeutics | Enanta Pharmaceuticals vs. Werewolf Therapeutics | Enanta Pharmaceuticals vs. Ikena Oncology |
| Evoke Pharma vs. Crinetics Pharmaceuticals | Evoke Pharma vs. Enanta Pharmaceuticals | Evoke Pharma vs. Amicus Therapeutics | Evoke Pharma vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |